Clinical trials
Completed Phase 1 Retinal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 2 |
| The New York Eye Cancer Center | 2 |
| Adverum Biotechnologies, Inc. | 1 |
| Gemini Therapeutics, Inc. | 1 |
| King Khaled Eye Specialist Hospital | 1 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 1 |
| OcuCure Therapeutics, Inc. | 1 |
| Opthea Limited | 1 |
| PYC Therapeutics | 1 |
| TargeGen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Diseases | 17 |
| Macular Degeneration | 5 |
| Macular Edema | 5 |
| Eye Diseases | 4 |
| Retinal Degeneration | 4 |
| Diabetic Retinopathy | 3 |
| Diabetes Mellitus | 2 |
| Uveitis | 2 |
| Blindness | 1 |
| Choroidal Neovascularization | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.